Hong Kong is the first country to experience a wave driven by the new NB.1.8.1 variant.
From the Hong Kong surveillance report, wastewater is the most consistent indicator. That indicator is still trending upwards, to the highest level since mid-2023.
#COVID19 #HongKong
🧵
Analysis of the impact of the new NB.1.8.1 variant in Hong Kong might be informative for those awaiting that variant in other countries.
Here’s the current variant picture for Hong Kong, showing the rapid “clean sweep” by the XDV.* variants, led by NB.1.8.1. In the JN.1 era (since late 2023) it has been very rare to see this, anywhere.
🧵
The data volumes are not high, which is a challenge when analysing most places these days. But from the 40 samples collected during April, XDV.*and NB.1.8.1 are at 88% – 100% frequency, which seems definite enough.
🧵
Considering the vaccinations available, there is of course a slow drift away from JN.1 as time goes on (it appeared in mid-2023), so there would be some loss of effectiveness. But I am hopeful it is marginal.
🧵
Of the Spike mutation differences vs JN.1, F456L and Q493E have been in almost everything circulating in for over a year, so there would be a lot of natural immunity to those. KP.2 is a bit closer to NB.1.8.1, for jurisdictions where that vaccine is available.
🧵
Optimistically, convergent evolution has presented the Hong Kong population with a novel combination, but a lot of that novelty has already been saturated into the population elsewhere eg in Australia.
🧵
But not all of the novelty has been seen before, as by definition NB.1.8.1. is a new combination of mutations.
So realistically there still seems to be a fair chance that places like Australia will also experience a really big wave.
🧵
Australia also has seasonality working against us, and the experts predict large waves of Influenza and RSV in our winter this year (see up this thread). Pulverised healthcare capacity has a snowball effect.
Here's the latest variant picture with a global scope, to late April.
Growth of the LP.8.1.* variant is holding at around 39%.
XDV.* (led by NB.1.8.1) looks like the next challenger, rising steadily to 13%
#COVID19 #Global #LP_8_1 #XDV #NB_1_8_1
🧵
Globally, the XDV.* variant clan (led by NB.1.8.1) is showing a strong but slowing growth advantage of 5.1% per day (36% per week) over the dominant LP.8.1.* variants. That now predicts a crossover in late May.
Strong growth advantages point to higher waves than for LP.8.1.*.
🧵
NB.1.8.1 was initially reported from Hong Kong, rising to 100% frequency. It has also shown sustained growth in several other countries in the region, plus Canada and the US - all adding to its credibility.
🧵
With the LP.8.1.* variant dominant from the global perspective, it is time to ponder which variant might drive the next wave.
The leading contenders at this point are XDV.* (led by NB.1.8.1), and XFG.*.
#COVID19 #NB_1_8_1 #XFG
🧵
I show them above using a log scale, so you can compare their growth rates vs the dominant LP.8.1.*. Note the recent sample volumes are quite low, so the right side of this chart might not be a representative picture.
🧵
NB.1.8.1 is descended from XDV.1.5.1. XDV was a recombinant of XDE and JN.1. XDE was a recombinant of GW.5.1 and FL.13.4 (both descended from XBB), so this represents the last current variant with any non-JN.1 ancestry.
🧵
Here's the latest variant picture with a global scope, to late April.
Growth of the LP.8.1.* variant appears to have peaked, and fell to around 39%.
XDV.* (led by NB.1.8.1) looks like the next challenger, rising strongly to 11%
#COVID19 #Global #LP_8_1 #XDV
🧵
Globally, the XDV.* variant clan (led by NB.1.8.1) is showing a strong growth advantage of 5.5% per day (39% per week) over the dominant LP.8.1.* variants. That predicts a crossover in mid-May.
That could point to higher waves than those seen for LP.8.1.*.
🧵
NB.1.8.1 was initially reported from Hong Kong, rising to 100% frequency. It has also shown sustained growth in several other countries in the region, plus Canada and the US - all adding to its credibility.
🧵